Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

David B Price,1,2 William Henley,1,3 José Eduardo Delfini Cançado,4 Leonardo M Fabbri,5 Huib AM Kerstjens,6 Alberto Papi,7 Nicolas Roche,8 Elif Şen,9 Dave Singh,10 Claus F Vogelmeier,11 Sara Barille,12 Elena Nudo,12 Victoria Carter,1 Derek Skinner,1 Rebecca Vella,1 George Georges13 1Obser...

Full description

Bibliographic Details
Main Authors: Price DB, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Barille S, Nudo E, Carter V, Skinner D, Vella R, Georges G
Format: Article
Language:English
Published: Dove Medical Press 2022-02-01
Series:International Journal of COPD
Subjects:
inhaled corticosteroids
pneumonia
copd
extrafine beclomethasone
fluticasone
Online Access:https://www.dovepress.com/interclass-difference-in-pneumonia-risk-in-copd-patients-initiating-fi-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/interclass-difference-in-pneumonia-risk-in-copd-patients-initiating-fi-peer-reviewed-fulltext-article-COPD

Similar Items